Table 10.
Drug/manipulat | Extinction training | Extinction retrieval | Longterm extinction | Route | Reference |
---|---|---|---|---|---|
HDAC1 KO (HPC) | ns | −# | ns | No drug | (Bahari-Javan et al., 2012) |
HDAC2 KO in forebrain CamKII neurons | ns | +*# | ns | No drug | (Morris et al., 2013) |
Vorinostat/SAHA | ns | + | ns | ip | (Fujita et al., 2012) |
ns | + ** | ns | ip | (Matsumoto et al., 2013) | |
ns | + ** | ns | ip | (Hait et al., 2014) | |
TSA (trichostatin A) | ns | +* | ns | ip, HPC | (Lattal et al., 2007) |
Sodium butyrate | − | + | + (SR) | ip, HPC | (Stafford et al., 2012) |
ns | + | ns | ip | (Itzhak et al., 2012) | |
ns | + | ns | ip, HPC | (Lattal et al., 2007) | |
Valproic acid | − | +* | ns | ip | (Bredy et al., 2007) |
+* | + (Ren-A) | ip | (Bredy & Barad, 2008) | ||
+ ** | + ** | + (SR, Ren-N) | ip | (Whittle et al., 2013) | |
MS-275 (entinostat) | − | + ** | + (SR, Ren-N) | ip | (Whittle et al., 2013) |
Cl-994 | ns | + *** | + (SR) | ip | (Graff et al., 2014) |
FTY720 (fingolimod) | − | + ** | ns | ip | (Hait et al., 2014) |
Partial extinction training: reduction of fear during the extinction training session was not to pre-conditioning levels,
facilitates rescue of impaired fear extinction;
facilitate remote memories combined with memory re-consolidation update paradigm;
extinction protocol based on a re-consolidation/update paradigm
+, Improved;-, impaired; ip, intraperitoneal injection; ns, not studied; HPC, intra-hippocampal administration; Ren-A, Fear renewal in the conditioning context; Ren-N, Fear renewal in a novel context; SR, spontaneous recovery; # reduced freezing levels at the beginning of extinction training